Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksPPLPHARMA
resources
PPLPHARMA
168.11-7.1 (-4.06%)
8 Jul, 12:00 AM

Annual Reports and Financial Documents

Piramal Pharma Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Piramal Pharma Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • Newspaper Publication4 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Advertisement for dispatch of notice of the 6th Annual General Meeting and E-Voting information
  • Business Responsibility and Sustainability Reporting (BRSR)3 Jul 2026
    Business Responsibility and Sustainability Reporting (BRSR)
    Business Responsibility and Sustainability Reporting for the Financial Year 2025-26
  • Reg. 34 (1) Annual Report3 Jul 2026
    Reg. 34 (1) Annual Report.
    Notice of the 6th Annual General Meeting and Annual Report for the financial year 2025-26
  • AGM3 Jul 2026
    Notice Of The 6Th Annual General Meeting And Annual Report For The Financial Year 2025-26
    Notice of the 6th Annual General Meeting and Annual Report for the financial year 2025-26
  • Closure of Trading Window29 Jun 2026
    Closure of Trading Window
    Please refer attached file
  • General23 Jun 2026
    Clarification On News Item Appearing On NDTV Profit Captioned - "Piramal Pharma Share Price Spikes Over 10% - What Is Driving The Rally?"
    Please refer attached file
  • Newspaper Publication19 Jun 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Advertisement for information regarding 6th Annual General Meeting of the Company
  • Allotment of ESOP / ESPS5 Jun 2026
    Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
    Please find enclosed intimation of allotment of ESOPs.
  • General3 Jun 2026
    Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
    Permanent revocation of closure directions for Company''s Dahej Site
  • Analyst / Investor Meet1 Jun 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • Reg.24(A)-Annual Secretarial Compliance22 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Please find enclosed herewith the Annual Secretarial Compliance Report for the Financial Year 2025-2026.
  • Analyst / Investor Meet19 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • General18 May 2026
    Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Successful Closure Of US FDA Inspection At Piramal Pharma'S Manufacturing Facility Located At Digwal, Telangana, India
    Please refer attached file
  • General10 May 2026
    Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
    Please refer attached file
  • Analyst / Investor Meet4 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Schedule of Analyst/ Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • Analyst / Investor Meet30 Apr 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Transcript of Conference Call on the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March, 2026
  • General29 Apr 2026
    Contact Details Of Key Managerial Personnel As Required Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
    Please refer attached file
  • Analyst / Investor Meet29 Apr 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Audio Recording of Conference Call on the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March, 2026
  • Change in Registered Office Address28 Apr 2026
    Announcement under Regulation 30 (LODR)-Change in Registered Office Address
    Please refer attached
  • Appointment of Company Secretary / Compliance Officer28 Apr 2026
    Appointment of Company Secretary and Compliance Officer
    Please refer attached details of appointment of Company Secretary and Compliance Officer

Frequently Asked Questions

Where can I download the annual report of Piramal Pharma Ltd.?
Annual reports of Piramal Pharma Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Piramal Pharma Ltd.?
Quarterly earnings results and presentations of Piramal Pharma Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Piramal Pharma Ltd. publish earnings call transcripts?
Earnings call transcripts of Piramal Pharma Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Piramal Pharma Ltd.?
Investor presentations and annual day presentations of Piramal Pharma Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Piramal Pharma Ltd.?
Corporate announcements and regulatory filings of Piramal Pharma Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Piramal Pharma Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Piramal Pharma Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Piramal Pharma Ltd.?
The ISIN (International Securities Identification Number) of Piramal Pharma Ltd. is INE0DK501011. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Piramal Pharma Ltd. listed?
Piramal Pharma Ltd. is listed on NSE and BSE. The NSE symbol is PPLPHARMA and the BSE code is -.
Where can I find the shareholding pattern of Piramal Pharma Ltd.?
The quarterly shareholding pattern of Piramal Pharma Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Piramal Pharma Ltd. on Sharpely?
Share price data for Piramal Pharma Ltd. is updated as of 8 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.